Fesoterodine Synthesis via Selective Esterification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current synthesis methods for Fesoterodine are complex, lengthy, and require protective groups, leading to reduced yields and industrialization challenges, necessitating an alternative process for high-purity production from low-cost starting materials.
Innovation Solution
A process involving the resolution of racemic compounds through diastereomeric salt formation with optically active organic acids, followed by selective esterification and reduction steps, utilizing phase-transfer reaction conditions for regioselective phenol hydroxyl group esterification, to produce Fesoterodine or its (S)-enantiomer with high enantiomeric purity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional synthetic methods are used to prepare Fesoterodine, then the product can be obtained with acceptable purity, but the process becomes complex and lengthy requiring protective groups
Solution Approach 1:
The invention extracts and eliminates the need for protective groups from the synthetic pathway. By using a modified route that starts from 4-bromophenol and incorporates the phenol hydroxyl group directly without protection/deprotection cycles, the process complexity is reduced while maintaining product purity through selective esterification steps
Solution Approach 2:
The synthesis is segmented into distinct modular stages: (i) preparation of the optically active compound with the phenol group, (ii) Grignard reaction to introduce the side chain, (iii) selective esterification of the phenol hydroxyl group. This segmentation allows each step to be optimized independently, reducing overall process complexity while ensuring high purity at each stage
2Reliability
If protective groups are used in the synthesis, then the phenol hydroxyl group can be protected during reactions, but the number of synthetic steps increases
Solution Approach 1:
The invention applies partial action by using selective esterification conditions that esterify only the phenol hydroxyl group while leaving the aliphatic hydroxyl group untouched. This is achieved through controlled reaction conditions (acid catalyst, specific temperature, stoichiometry) that provide sufficient selectivity without requiring complete protection of all hydroxyl groups, thereby reducing the number of steps while maintaining reliability
Solution Approach 2:
The invention changes reaction parameters (acid catalyst type, temperature, solvent, stoichiometry) to achieve selective esterification of the phenol hydroxyl group. By optimizing these parameters, the process achieves the desired selectivity without requiring additional protection/deprotection steps, thus improving productivity while maintaining reaction reliability
3Manufacturing precision
If multiple synthetic steps are used, then the desired product can be obtained, but the overall yield decreases
Solution Approach 1:
The invention performs preliminary action by establishing the optical purity early in the synthesis through resolution of the racemic Grignard reagent intermediate. This early establishment of chirality allows subsequent steps to proceed without additional resolution steps, reducing the total number of steps and minimizing material loss while ensuring high enantiomeric purity in the final product
Solution Approach 2:
The invention maintains continuity of useful action by designing a synthetic pathway where each step builds directly on the previous one without interruption for protection/deprotection cycles. The Grignard reaction, followed by selective esterification and final purification, creates a continuous flow of material transformation that minimizes losses and maintains high overall yield while achieving the required product purity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method simplifies the synthesis, increases purity, and reduces the number of steps, enabling efficient industrial-scale production of Fesoterodine from low-cost starting materials, while maintaining high enantiomeric purity and regioselectivity.
Implementation Method 1
the resolution of the corresponding racemic compound of formula (II) through formation of a diastereomeric salt thereof with an optically active organic acid
Implementation Method 2
utilizing phase-transfer reaction conditions for regioselective phenol hydroxyl group esterification
Data Source
AI summary
A process for the preparation of (R)-2-(3-diisopropylamino-1-phenylpropyl)-4-(hydroxymethyl)-phenol isobutyrate (Fesoterodine), its (S)-enantiomer, and novel intermediates useful in the synthesis.